Search

Your search keyword '"Prato S"' showing total 1,680 results

Search Constraints

Start Over You searched for: Author "Prato S" Remove constraint Author: "Prato S"
1,680 results on '"Prato S"'

Search Results

2. GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes

4. Towards a marine strategy for the deep Mediterranean Sea: Analysis of current ecological status

11. Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

14. Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study

15. Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening

17. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

18. Complex neurodevelopmental disorder in a preterm child with unilateral cerebellar hemorrhage

19. Rare diseases in clinical endocrinology: a taxonomic classification system

20. The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review

33. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

34. Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults:a meta-analysis

35. COVID-19 Vaccination and Asymptomatic Infection - Effect of BNT162b2 mRNA Vaccine on the Incidence of COVID-19 and Duration of Sick Leave Among Healthcare Workers

46. Umstellung auf iGlarLixi gegenüber der weitergeführten Behandlung mit einem GLP-1-Rezeptoragonisten bei unzureichend kontrolliertem Typ-2-Diabetes: die randomisierte LixiLan-G-Studie

47. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

48. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion

49. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

50. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study

Catalog

Books, media, physical & digital resources